These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9345463)

  • 1. Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis.
    Liu X; Yao DL; Webster H
    Mult Scler; 1995 Apr; 1(1):2-9. PubMed ID: 9345463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.
    Yao DL; Liu X; Hudson LD; Webster HD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6190-4. PubMed ID: 7541143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis.
    Liu X; Linnington C; Webster HD; Lassmann S; Yao DL; Hudson LD; Wekerle H; Kreutzberg GW
    J Neurosci Res; 1997 Mar; 47(5):531-8. PubMed ID: 9067862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis.
    Yao DL; Liu X; Hudson LD; Webster HD
    Life Sci; 1996; 58(16):1301-6. PubMed ID: 8614286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis.
    Liu X; Yao DL; Bondy CA; Brenner M; Hudson LD; Zhou J; Webster HD
    Mol Cell Neurosci; 1994 Oct; 5(5):418-30. PubMed ID: 7529631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic relapsing experimental autoimmune encephalomyelitis: effects of insulin-like growth factor-I treatment on clinical deficits, lesion severity, glial responses, and blood brain barrier defects.
    Li W; Quigley L; Yao DL; Hudson LD; Brenner M; Zhang BJ; Brocke S; McFarland HF; Webster HD
    J Neuropathol Exp Neurol; 1998 May; 57(5):426-38. PubMed ID: 9596413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor.
    Mohamed A; Shoker A; Bendjelloul F; Mare A; Alzrigh M; Benghuzzi H; Desin T
    Biomed Sci Instrum; 2003; 39():440-5. PubMed ID: 12724933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
    Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
    Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair.
    Mohajeri M; Sadeghizadeh M; Najafi F; Javan M
    Neuropharmacology; 2015 Dec; 99():156-67. PubMed ID: 26211978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
    Yin LL; Lin LL; Zhang L; Li L
    Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of epidermal growth factor and growth hormone releasing peptide-6 improves clinical recovery in experimental autoimmune encephalitis.
    del Barco DG; Montero E; Coro-Antich RM; Brown E; Suarez-Alba J; Lopez L; Subirós N; Berlanga J
    Restor Neurol Neurosci; 2011; 29(4):243-52. PubMed ID: 21697595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
    J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of digital technology to asses the severity of the Experimental Allergic Encephalomyelitis (EAE) spinal cord lesion.
    Mohamed A; Tarhuni H; Dufan T; Benghuzzi H; Tucci M
    Biomed Sci Instrum; 2004; 40():419-23. PubMed ID: 15133994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats.
    Yuan XQ; Qiu G; Liu XJ; Liu S; Wu Y; Wang X; Lu T
    Neuroimmunomodulation; 2012; 19(4):201-8. PubMed ID: 22441536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis].
    Zaprianova E; Deleva D; Bakalska M; Filchev N
    Morfologiia; 1997; 112(6):25-8. PubMed ID: 9606089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
    Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
    J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP; Piddlesden S; Morgan BP; Reynolds R
    Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral administration of pig spinal cord hydrolysate on clinical and histopathological symptoms of experimental allergic encephalomyelitis in rats.
    Kasarełło K; Gadamski R; Piotrowski P; Kurzepa K; Kwiatkowska-Patzer B; Lipkowski AW
    Folia Neuropathol; 2015; 53(2):128-38. PubMed ID: 26216115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine.
    Paul C; Bolton C
    J Pharmacol Exp Ther; 2002 Jul; 302(1):50-7. PubMed ID: 12065699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.